Objective: Patients with rectal cancer receive curative radiotherapy towards the pelvis for 5 weeks. Little is known about the impact of radiotherapy on dietary intake and nutritional status. The objective was to examine whether curative radiotherapy for rectal cancer promoted altered intake of energy and nutrients, and change in nutritional indicators. Design: Prospective study. Setting: Department of Oncology in a tertiary care hospital. Subjects: A total of 31 consecutive patients receiving radiotherapy for rectal cancer (50 Gray). Interventions: A 7-day food intake registration, body weight, upper arm circumference, and analyses of blood samples were performed at the start and the end of radiotherapy, and at follow-up 4-6 weeks and 1 year after the end of radiotherapy. Results: At the end of 5 weeks of radiotherapy, the mean daily energy intake was reduced by 15% from 8.9 to 7.6 MJ as compared with baseline (P ¼ 0.002), and the intake of several nutrients was reduced (Po0.01). The percentages of energy derived from fat, protein, and carbohydrates did not change, nor did the nutrient density. A transient body weight reduction ofo1 kg was observed (P ¼ 0.009). Serum concentrations of vitamin A and 25-OH vitamin D did not change during radiotherapy. The daily intake of energy and nutrients, and body weight, had increased towards pretreatment values 4-6 weeks after radiotherapy. Conclusions: Radiotherapy for rectal cancer caused a transient reduction in energy intake and nutritional indicators. The nutritional quality of the diet was unchanged during radiotherapy.
Introduction
Colorectal cancer is one of the most common cancers in developed countries. In patients with locally advanced rectal cancer, curative treatment often includes multimodality treatment with radiotherapy and chemotherapy in addition to surgery. Preoperative radiotherapy of nonresectable primary tumours or recurrent tumours may reduce the tumour size and eradicate microscopic disease, thereby increasing the possibility of radical surgery and survival (Van Cutsem et al., 2002) . If curative surgery is not possible, radiotherapy may offer good palliation. In operated patients with a high risk of tumour recurrence, postoperative radiotherapy with concurrent chemotherapy may decrease the risk of local recurrence (Tveit et al., 1997) .
Dietary intake and nutritional status is related to tumour burden (Ravasco et al., 2003b) , but also to the site of the primary tumour. Patients with advanced or metastatic disease are more likely to have cachexia, characterized by progressive weight loss and asthenia, than patients with localized disease receiving adjuvant therapy. Patients receiving radiotherapy for head and neck cancer are at high risk of nutritional depletion caused by dysphagia and mucositis (Isenring et al., 2003 (Isenring et al., , 2004 , both because of the tumour location and the high dose of radiotherapy. Patients receiving curatively intended radiotherapy for rectal cancer may be considered to be at intermediate risk of nutritional depletion. These patients have localized disease without distant metastasis, and most are in relatively good general condition. However, side effects of pelvic radiation therapy are diarrhoea and malabsorption (Yeoh et al., 1993) . At the end of radiotherapy, these patients have transiently increased diarrhoea, fatigue, and loss of appetite (Guren et al., 2003) . Little is known of the impact of curatively intended pelvic radiotherapy on food intake and nutritional status among patients with rectal cancer.
The aims of the present study were to assess the dietary intake and nutritional status of patients receiving curative radiotherapy for rectal cancer and to investigate whether this was compromised during radiotherapy.
Materials and methods
Patients scheduled to receive curative radiotherapy (50 Gy) for rectal cancer were included in a prospective study evaluating quality of life (QoL) and side effects of treatment (Guren et al., 2003) , using the EORTC questionnaires QLQ-C30 (Aaronson et al., 1993) and QLQ-CR38 (Sprangers et al., 1999) , and a 5-day symptom diary regarding defecation, pain, appetite, and nausea, based on the Common Toxicity Criteria (Vantongelen and Hawthorn, 1993) . Only patients with relatively good performance status, ECOG 0 or 1, were included. Of the patients included in the QoL study, consecutive patients were asked to complete a 7-day prospective dietary record. In addition, body weight and upper arm circumference (UAC) were measured, body mass index (BMI) calculated, and blood samples drawn. Data were collected at the onset of radiotherapy, at the completion of 5 weeks of radiotherapy, and at follow-up 4-6 weeks after completed therapy (before surgery for patients receiving preoperative radiotherapy). A total of 31 patients completed the registration at baseline and at least one additional time. At 1 year after radiotherapy, data were obtained from 14 of 19 patients alive.
There were no significant differences between the patients who completed the dietary records and those who did not, concerning baseline body weight, BMI, UAC, haemoglobin, albumin, or QoL scales/items such as overall QoL, physical function, fatigue, appetite, pain, or nausea.
The radiotherapy was preferably given by one posterior and two lateral radiation fields (three-field technique), although in 23% of the patients two opposing anteriorposterior fields were given. Conventional radiotherapy was used with 25 daily fractions of 2 Gy, to a total of 50 Gy during 5 weeks. Patients irradiated preoperatively were re-evaluated after 4 weeks, and surgery was performed shortly thereafter. Patients irradiated postoperatively received concomitant chemotherapy with 5-fluorouracil and leucovorin (intravenous bolus infusions for two consecutive days in weeks 1, 3, and 5), slightly modified from that used in a Nordic study (Tveit et al., 1997) ; these patients were invited to a follow-up after 6 weeks.
The patients completed a 7-day prospective dietary record at each time point. A structured, precoded questionnaire with household measures was used (Becker et al., 1998) , and additional dietary supplements were reported. In-patients ate hospital food, and recipes were obtained from the hospital kitchen. For patients who had home-cooked food, common norms for recipes and household measures were used (Blaker and Aarsland, 1989 (Henriksen et al., 2005) . QoL data were available in 23 patients at all assessment times, and were analysed as previously described (Guren et al., 2003) . The regional ethics committee approved the study and all subjects signed an informed consent.
Statistics Differences in energy intake and nutritional indicators as compared with baseline values were normally distributed. Comparisons with baseline values were analysed using paired student's t-tests. QoL data were not normally distributed, and changes with baseline were analysed by Wilcoxon signed ranks test, and correlations were analysed with Spearman's tests. Owing to the multitude of tests employed, a two-tailed significance level of 0.01 was used. P-values between 0.01 and 0.05 are presented in the tables. SPSS version 11.0 was used for statistical analyses (SPSS Inc.).
Results

Patients and treatment
The registration of dietary intake was completed by 31 patients at the start of radiotherapy, 30 at the end of radiotherapy, 23 at follow-up 4-6 weeks after radiotherapy, and 14 at follow-up after 1 year. The median age was 65.7 years, 18 patients (58%) were males, and 13 (42%) females. A total of 18 patients (58%) received preoperative radiotherapy, 10 for primary and 8 for recurrent tumour, and 13 patients (42%) had postoperative chemoradiotherapy. There were no significant differences in energy intake or weight loss between patients receiving preoperative or postoperative chemotherapy, and data are presented together. Patients with one or more dietary records missing were compared with patients providing complete data sets; there were no differences regarding baseline energy intake, body weight, or BMI.
Baseline dietary intake
The mean daily intake of energy and nutrients at baseline are shown in Table 1 . A larger percentage of energy was derived from fat and sugar, and a smaller percentage from other carbohydrates than in the national recommendations (National Nutrition Council, 1997). The daily intake of dietary fibre, vitamin D, a-tocopherol, and magnesium was low, whereas the mean intake of other nutrients exceeded the national recommendations for healthy individuals.
Nutrient intake at the end of radiotherapy At the end of radiotherapy, the daily energy intake was decreased by 15% (P ¼ 0.002) as compared to baseline (Table 2) . During radiotherapy, the dietary intake of fat was reduced by 15% (P ¼ 0.002), of protein by 10% (P ¼ 0.01), and of carbohydrates by 8% (P ¼ 0.04). The percentages of energy derived from these nutrients remained constant during radiotherapy. The intake of fibre, saturated and monounsaturated fat was reduced during radiotherapy, while the intake of sugar and polyunsaturated fat remained unaltered. The intake of calcium, magnesium, retinol equivalents, thiamine, riboflavin, and niacin was reduced at the end of radiotherapy as compared with baseline, whereas the intake of vitamins C, D, a-tocopherol, and iron was unchanged. The intake of vitamins per 10 MJ was similar to baseline values.
At the end of radiotherapy, the intake of dietary fibre, calcium, iron, vitamin D, and a-tocopherol was below the recommended intake, and the intake of magnesium, thiamine, riboflavin, and niacin was borderline.
At the end of radiotherapy, 37% of the patients had a reduction in energy intake of 415%. These patients did not differ from the other patients concerning baseline energy intake, BMI, or serum albumin levels. Most of these patients (73%) received postoperative radiotherapy.
Nutrient intake 4-6 weeks after radiotherapy At follow-up 4-6 weeks after radiotherapy, the daily intake of energy and nutrients had increased towards baseline values ( Table 2 ). The intake of several nutrients was still somewhat lower than at baseline, but this was not significant with the stringent criteria of Po0.01 (with the exception of monounsaturated fatty acids). The percentages of energy derived from fat, carbohydrates, and protein were not different from that at baseline, nor was the intake of vitamins per 10 MJ.
Nutritional indicators
Mean BMI at the start of radiotherapy was 25.2 kg/m 2 (Table 3) . At baseline, one patient (3%) was underweight, 13 (42%) had normal weight, 15 (48%) were overweight, and 2 (6%) were obese. At the end of radiotherapy, body weight, BMI, and UAC were significantly lower than at baseline. Serum concentrations of haemoglobin and albumin were also significantly lower at the end of radiotherapy than at baseline, while there was no change in serum IgG level. At follow-up 4-6 weeks after end of radiotherapy, there was no significant change compared with baseline, except for haemoglobin, which remained lower.
The serum concentrations of retinol and 25-OH vitamin D did not change during radiotherapy (Table 3) . Serum Nutrition during radiotherapy MG Guren et al concentrations of retinol were within the reference range in 93-100% of the patients, whereas 12-27% of the patients had 25-OH vitamin D concentrations below the reference range.
One-year follow-up At 1 year after completed radiotherapy, 14 of the 19 patients alive completed the registration. These 14 subjects did not significantly differ in energy intake, body weight, or serum albumin concentration at baseline from the five patients who did not complete the registration. The mean energy intake was 8.9 MJ, and the percentages of energy derived from fat, protein, carbohydrates, and alcohol, were 38.3, 15.6, 42.5, and 3.5%, respectively. Compared to the start of radiotherapy, there was no significant difference in energy intake or the percentage of energy derived from fat, protein, or carbohydrates.
Dietary supplements
Vitamin supplements were self-administered by 23 patients (74%) during the study, but only seven patients took vitamin supplements at all registration times. The frequency of patients taking vitamin supplements was 45, 37, 35, and 71%, at the four time points, respectively. Several different types of vitamin supplements were taken. Dietary intake of vitamin D was lower than recommended in 81-93% of the patients at different time points. With supplementation, 36-70% of the patients had low intake. There was no relation between having a low dietary intake and taking vitamin D supplements.
Quality-of-life related to radiotherapy
At the end of radiotherapy, patients experienced increased fatigue, loss of appetite, diarrhoea, and gastrointestinal problems (Table 4 ). Appetite was registered by both the QoL questionnaire and the symptom diary. Reduced appetite (410 points on a scale from 0-100) was reported by 44% of the patients at the end of radiotherapy compared to baseline. Energy intake was inversely correlated with appetite loss as reported in the QoL questionnaires (r ¼ À0.68, P ¼ 0.001), as well as the symptom diary (r ¼ À0.61, Po0.001). Energy intake was also inversely correlated with alterations in taste (QoL questionnaire) (r ¼ À0.49, P ¼ 0.009). There was no correlation between energy intake and overall QoL or diarrhoea, or between weight loss and overall QoL (data not shown).
Discussion
Our present study showed that the daily intake of energy and several nutrients was reduced during radiotherapy, whereas the percentages of energy derived from fat, protein, and carbohydrates did not change, nor did the nutrient density.
At follow-up 4-6 weeks after the end of radiotherapy, the daily intake of energy and nutrients had increased towards pretreatment amounts. A transient weight reduction was observed in the magnitude as expected from the reduced dietary intake. There are few publications on the nutrient intake during curative pelvic radiotherapy, and none on homogenous patients with rectal cancer. Our findings of significantly reduced dietary intake (15%, P ¼ 0.002) are in contrast to earlier reports on patients with gynaecological and urological cancer reporting similar dietary intake during radiotherapy (Bruning et al., 1985; Hulshof et al., 1987; Bye et al., 1993; Pia et al., 2001 ). Ravasco et al., found that nutritional intervention promoted increased energy intake among a heterogeneous population of patients with colorectal cancer during radiotherapy (Ravasco et al., 2003a) . These studies were also hampered by variable radiation treatment schedules (radiation dose, treatment volume, and treatment time). Nutrition during radiotherapy MG Guren et al A 7-day food registration for each patient was used in our present study to provide robust and detailed data on dietary changes with time. Prospective registration on precoded questionnaires provided detailed information of the food intake, and repeated registrations enabled analyses of the changes during radiotherapy. In accordance with the observed reduction in energy intake, a significant reduction in serum albumin, body weight and UAC was observed. The observed mean weight reduction of 0.5 kg was probably of minor clinical significance. A weight reduction of about 1 kg corresponds approximately to a reduction in daily energy intake of 1 MJ during 5 weeks. It is known that clinical symptoms generally increase towards the end of the radiation treatment period, and it is likely that the reduced energy intake was most pronounced at end of the treatment period. Increased fatigue is observed at the end of radiotherapy (Guren et al., 2003) , and these patients may have reduced energy requirement due to less physical activity. There was a clinically significant reduction in appetite towards the end of radiotherapy. The inverse correlation observed between appetite loss and energy intake during radiation therapy suggests that changes in appetite and taste might be important for the reduced energy intake.
The initial reduction in energy intake was diminished 4-6 weeks after the end of radiation therapy. Energy intake and nutritional indicators increased towards values observed at the start of treatment. This is in line with the transient worsening of gastrointestinal symptoms observed during radiotherapy, with restoration to baseline symptoms 4-6 weeks after completed radiotherapy (Guren et al., 2003) .
There was no significant change in the percentages of energy derived from fat, protein, or carbohydrates at the different time points, suggesting that the reduction in energy intake was caused by reduced general food intake, and not by change in dietary composition. This is supported by the observation that there were no major differences in the nutrient density (intake of different nutrients per 10 MJ) at the different time points. The reported dietary intakes were adequate as compared to the recommended intake of vitamins and minerals for healthy subjects, except for vitamin D. The intake of vitamin D is also low in the general Norwegian population (Johansson and Solvoll, 1999) and in medical inpatients (Thomas et al., 1998) .
Body weight, BMI, UAC, and albumin were used as nutritional indicators in our present study. Although these anthropometric and biochemical measures are widely used, they have limitations and may be difficult to interpret (Tchekmedyian et al., 1992) . It would have been preferable to apply the patient-generated subjective global assessment (PG-SGA), which has been developed and validated for cancer patients (Detsky et al., 1987; Ottery 1996; Bauer et al., 2002) . The changes observed in our anthropometric and biochemical measures support the finding of a significant reduction in food and energy intake during radiotherapy.
Vitamin and mineral supplements were used by a large proportion of patients either during or after radiotherapy.
However, the use included several different brands and was highly variable, and there was no correlation between dietary vitamin intake and the use of supplementation.
The results were compared with data from a representative national dietary survey among Norwegians (Johansson and Solvoll, 1999) , in which healthy individuals (N ¼ 2672) had completed a food frequency questionnaire, and data were presented according to gender and age groups. The daily energy intake at baseline in our present study was 8.9 MJ, which is comparable with the Norkost study where the daily energy intake among men (age 60-69 years) was 8.7 MJ and among women 7.2 MJ (Johansson and Solvoll, 1999) .
In conclusion, the patients receiving curative radiotherapy for rectal cancer appeared to be in good nutritional status at the start of therapy. Radiation therapy caused a significant reduction in energy intake, whereas the nutrient density remained unchanged. There was an initial weight loss accompanied by some changes in nutritional indicators during radiotherapy. Since the observed changes were moderate and the clinical situation improved after completed radiotherapy we suggest there is no need for routine nutritional intervention among patients with good performance status at the start of (neo)adjuvant radiotherapy for rectal cancer. However, patients with nutritional deficiencies or low energy intake at the start of treatment may probably benefit from nutritional intervention.
